- Tytuł:
- Sutimlimab provides clinically meaningful improvements in patient‐reported outcomes in patients with cold agglutinin disease: Results from the randomised, placebo‐controlled, Phase 3 CADENZA study.
- Autorzy:
- Źródło:
-
European Journal of Haematology . Mar2023, Vol. 110 Issue 3, p280-288. 9p.
Czasopismo naukowe